Keywords: b-ms, earnings, hit, 714m, 1st-qtr, usa-based, drug
B-MS's earnings hit $714M in 1st-qtr
Article | 08 May 2006
USA-based drug major Bristol-Myers Squibb says that its first-quarter 2006 net earnings were $714.0 million, or $0.36 per share, up 32.7% compared with the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
